Close

Dr Kevin Wing

BSc MSc PhD

Assistant Professor
of Epidemiology

Room
248c

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I initially trained as a Biochemist, graduating from Bristol University with a BSc (Hons) in 1998. I subsequently completed an MSc in Information Technology at Glasgow University. I have 10 years experience working on technology and processes relating to the licensing and regulation of medicines. In 2010 I completed the MSc Epidemiology at LSHTM and completed my PhD at LSHTM in October 2015.

Affiliations

Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology

Teaching

I am co-Course Organiser for the Certificate of Pharmacoepidemiology and Pharmacovigilance (PEPI) and a tutor on the DL Statistical Methods in Epidemiology MSc module (EPM202).

Research

I have a general interest in the use of data collected as part of routine clinical care for studies of epidemiology and pharmacoepidemiology. My current main area of research focuses on how the preparation and analysis of randomised controlled trial-analogous cohorts in non-interventional data can be used to help improve the understanding of drug treatment effects in people who were underrepresented or excluded from trials. This has included a focus on Chronic Obstructive Pulmonary Disease (COPD) drug treatment effects within UK primary and secondary care, and I am also involved in projects utilising similar approaches for studying the treatment effects of cardiovascular drugs.

Other research I am either involved in currently or have worked on recently includes investigation of techniques relating to quantitative bias analysis, improving standards for performing pharmacoepidemiological research, quantification of the risk of serious drug-induced liver injury associated with a range of drug treatments, and studies of Ebola using data collected as part of clinical care during and after the 2013-16 West African outbreak. During the COVID-19 pandemic I have been involved in research using the OpenSAFELY platform, including looking at the effect of household composition on COVID-19 outcomes by ethnicity, the dffering risk of severe outcomes by SARS-CoV-variant and COVID survival and diabetes.

Publications

 

Research Area
Clinical databases
Drug discovery and development
Primary care
Electronic health records
Outbreaks
Randomised controlled trials
Discipline
Genetic epidemiology
Pharmacoepidemiology
Epidemiology
Medicine
Disease and Health Conditions
Eye diseases
Emerging Infectious Disease
Hepatitis
Respiratory disease
Country
United Kingdom
Kenya
Sierra Leone
Region
World

Selected Publications

Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study.
Brellier F; Pujades-Rodriguez M; Powell E; Mudie K; Mattos Lacerda E; Nacul L; Wing K
2022
PloS one
Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform.
Wing K; Grint DJ; Mathur R; Gibbs HP; Hickman G; Nightingale E; Schultze A; Forbes H; Nafilyan V; Bhaskaran K
2022
International Journal of Epidemiology
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.
Grint DJ; Wing K; Houlihan C; Gibbs HP; Evans SJW; Williamson E; McDonald HI; Bhaskaran K; Evans D; Walker AJ
2021
Clinical infectious diseases
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
Grint DJ; Wing K; Williamson E; McDonald HI; Bhaskaran K; Evans D; Evans SJ; Walker AJ; Hickman G; Nightingale E
2021
Eurosurveillance
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
2020
The European respiratory journal
Improving health information systems during an emergency: lessons and recommendations from an Ebola treatment centre in Sierra Leone.
Oza S; Wing K; Sesay AA; Boufkhed S; Houlihan C; Vandi L; Sebba SC; McGowan CR; Cummings R; Checchi F
2019
BMC MEDICAL INFORMATICS AND DECISION MAKING
Development of a Pediatric Ebola Predictive Score, Sierra Leone1.
Fitzgerald F; Wing K; Naveed A; Gbessay M; Ross JCG; Checchi F; Youkee D; Jalloh MB; Baion DE; Mustapha A
2018
Emerging infectious diseases
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).
Langan SM; Schmidt SA; Wing K; Ehrenstein V; Nicholls SG; Filion KB; Klungel O; Petersen I; Sorensen HT; Dixon WG
2018
BMJ (Clinical research ed.)
Surviving Ebola: A historical cohort study of Ebola mortality and survival in Sierra Leone 2014-2015.
Wing K; Oza S; Houlihan C; Glynn JR; Irvine S; Warrell CE; Simpson AJH; Boufkhed S; Sesay A; Vandi L
2018
PloS one
Risk in the \"Red Zone\": Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus Disease.
Fitzgerald F; Wing K; Naveed A; Gbessay M; Ross JCG; Checchi F; Youkee D; Jalloh MB; Baion D; Mustapha A
2017
Clinical infectious diseases
Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
2017
The Journal of antimicrobial chemotherapy
Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury.
Wing K; Bhaskaran K; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
2016
BMJ open
See more Publications